ESR1 and invasive ductal breast carcinoma: A core needle biopsy of the breast lesion confirmed invasive ductal carcinoma with 5% of estrogen receptor (ER) expression, negative progesterone receptor and human epidermal growth factor receptor 2 expression, and 80% of Ki-67 expression.